• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆的接触激活:人高分子量激肽原的构效关系

Contact activation of plasma: structure-activity relationships of human high molecular weight kininogen.

作者信息

Kerbiriou D, Griffin J H

出版信息

Adv Exp Med Biol. 1979;120B:153-61.

PMID:517232
Abstract

Human high MW kininogen can be isolated as a single polypeptide chain of 110,000 MW. Purified human plasma kallikrein cleaves this molecule to give a disulfide-linked, two chain molecule, free of kinin, that retains full clotting activity. Following reduction and carboxymethylation of the two chain molecule, a light chain can be isolated that quantitatively retains the full coagulant activity of the native molecule. During contact activation in normal human plasma a rapid cleavage of high MW kininogen along with kinin liberation occurs in a reaction that is dependent upon the presence of prekallikrein and Factor XII (Hageman factor).

摘要

人高分子量激肽原可作为一条分子量为110,000的单多肽链分离出来。纯化的人血浆激肽释放酶切割该分子,产生一个无激肽的、通过二硫键连接的双链分子,该分子保留了全部凝血活性。在双链分子进行还原和羧甲基化后,可分离出一条轻链,该轻链定量保留了天然分子的全部凝血活性。在正常人血浆的接触激活过程中,高分子量激肽原会快速裂解并伴随激肽释放,这一反应依赖于前激肽释放酶和因子XII(哈格曼因子)的存在。

相似文献

1
Contact activation of plasma: structure-activity relationships of human high molecular weight kininogen.血浆的接触激活:人高分子量激肽原的构效关系
Adv Exp Med Biol. 1979;120B:153-61.
2
Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.人高分子量激肽原。血浆接触激活过程中分子的结构-功能关系及蛋白水解研究。
J Biol Chem. 1979 Dec 10;254(23):12020-7.
3
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.人高分子量激肽原的裂解显著增强其凝血活性。该分子作为前辅因子存在的证据。
J Clin Invest. 1984 Apr;73(4):954-62. doi: 10.1172/JCI111319.
4
Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.菲茨杰拉德性状中的激肽原缺乏:高分子量激肽原在凝血和纤维蛋白溶解中的作用。
J Lab Clin Med. 1976 Feb;87(2):327-37.
5
Characterization of guinea-pig high-molecular-weight kininogen as multi-functional molecule.豚鼠高分子量激肽原作为多功能分子的特性研究。
Biochim Biophys Acta. 1987 Aug 21;914(3):259-74. doi: 10.1016/0167-4838(87)90285-8.
6
Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.前激肽释放酶和因子XI与高分子量激肽原及其轻链结合的研究。
Proc Natl Acad Sci U S A. 1979 Oct;76(10):4862-6. doi: 10.1073/pnas.76.10.4862.
7
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.接触激活过程中人类凝血因子Ⅻ的结合与裂解特性。正常血浆与缺乏因子Ⅺ、前激肽释放酶或高分子量激肽原的血浆的比较。
J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741.
8
Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.在没有激肽释放酶的情况下,通过Hageman因子的作用从高分子量激肽原释放激肽。
J Biol Chem. 1983 Jul 25;258(14):8963-70.
9
Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.人类高分子量(HMW)激肽原的研究。II. 人血浆激肽释放酶作用下HMW激肽原的结构变化
J Biochem. 1981 May;89(5):1465-73. doi: 10.1093/oxfordjournals.jbchem.a133339.
10
Molecular assembly in the contact phase of the Hageman factor system.哈格曼因子系统接触相中的分子组装。
Am J Med. 1979 Oct;67(4):657-64. doi: 10.1016/0002-9343(79)90253-5.